Icosapent

APHIS BRS announced updated resources on Sept 12, 2024, to aid developers in preparing permit applications, including a Permit User Guide. These updates align with the May 2024 Plan for Regulatory Reform, supporting Executive Order 14081 on biotechnology innovation.

In February 2024, FDA issued final guidance on the regulatory pathway for foods from genome-edited plants, introducing a streamlined premarket meeting option for lower-risk plants. This aligns with the 2017 update to the Coordinated Framework and the Biden Administration's 2022 Executive Order on biotechnology. The guidance confirms FDA's New Plant Variety policy applies to such foods but introduces a less information-intensive premarket meeting pathway. Developers can choose between this new pathway or the traditional premarket consultation, both voluntary. FDA emphasizes allergen labeling compliance and safety concerns, particularly regarding allergenicity risks.

EPA scientists alleged managers under Trump pressured them to downplay new chemicals' risks, leading to retaliation. The EPA inspector general confirmed some retaliation, prompting corrective action calls and training on scientific integrity and whistleblower protection.

EPA whistleblowers were retaliated against for differing opinions on new chemical risk assessments, violating scientific integrity policy. Despite claims of restored integrity under Biden, Inspector General Sean O’Donnell says more work is needed. Kyla Bennett, representing the whistleblowers, argues scientific integrity has not improved and retaliation continues.

Agricultural Biotechnology Market valued at USD 51.12B in 2023, projected to reach USD 100.32B by 2031, growing at a CAGR of 9.70%. Key drivers include food security, sustainable agriculture, consumer interest in nutrition, pest control, and advancements in gene editing. Challenges involve public perception, ethical considerations, economic access, and integration with conventional techniques. Key players include Arcadia Biosciences, Thermo Fisher Scientific, Bayer AG, Biocentury Transgene Co., Ltd, Vilmorin & Cie, Eurofins Scientific, LGC Biosearch Technologies.